<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ANomination_committee</id>
	<title>Definition:Nomination committee - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ANomination_committee"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Nomination_committee&amp;action=history"/>
	<updated>2026-05-03T00:27:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Nomination_committee&amp;diff=20567&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Nomination_committee&amp;diff=20567&amp;oldid=prev"/>
		<updated>2026-03-18T02:33:06Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏢 &amp;#039;&amp;#039;&amp;#039;Nomination committee&amp;#039;&amp;#039;&amp;#039; is a board-level governance body responsible for identifying, evaluating, and recommending candidates for board membership and senior executive positions within an insurance company. In the insurance sector, the nomination committee carries particular weight because regulators across major markets — including those enforcing [[Definition:Solvency II | Solvency II]], the UK&amp;#039;s Senior Managers and Certification Regime ([[Definition:Senior Managers and Certification Regime (SM&amp;amp;CR) | SM&amp;amp;CR]]), and equivalent frameworks in Hong Kong, Singapore, and other jurisdictions — require insurers to demonstrate that individuals in [[Definition:Key function holder | key function]] and [[Definition:Senior management function | senior management]] roles satisfy [[Definition:Fit and proper requirements | fit and proper]] criteria covering competence, integrity, and financial soundness.&lt;br /&gt;
&lt;br /&gt;
⚙️ The committee&amp;#039;s remit extends well beyond simply filling vacancies. It assesses the board&amp;#039;s collective skills, experience, and diversity against the insurer&amp;#039;s strategic needs and [[Definition:Risk profile | risk profile]], identifying gaps that new appointments should address. For instance, a property and casualty insurer expanding into [[Definition:Cyber insurance | cyber risk]] may need a board member with technology or cybersecurity expertise, while a [[Definition:Life insurance | life insurer]] entering [[Definition:Asset management | asset management]] may seek investment experience. The nomination committee also oversees [[Definition:Succession planning | succession planning]] for the CEO, chief financial officer, [[Definition:Chief risk officer (CRO) | chief risk officer]], chief actuary, and other roles subject to regulatory approval. Under Solvency II, the committee is explicitly recognized as part of the [[Definition:System of governance | system of governance]], and [[Definition:European Insurance and Occupational Pensions Authority (EIOPA) | EIOPA]] expects it to operate with documented terms of reference, meet regularly, and report to the full board. In the [[Definition:Lloyd&amp;#039;s of London | Lloyd&amp;#039;s]] market, managing agents similarly maintain nomination processes aligned with PRA and FCA expectations.&lt;br /&gt;
&lt;br /&gt;
💡 The nomination committee&amp;#039;s effectiveness has a cascading impact on an insurer&amp;#039;s governance quality, regulatory standing, and strategic execution. Boards that lack the right mix of insurance, financial, and operational expertise are more likely to make poor strategic decisions — whether in [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]], [[Definition:Capital management | capital management]], or [[Definition:Product development | product innovation]]. Regulators have become more assertive in challenging board composition: several supervisory authorities now routinely interview proposed appointees and can block appointments that do not meet [[Definition:Fit and proper requirements | fit and proper]] standards. For the committee itself, independence is paramount — best practice requires that a majority of members, and certainly the chair, be [[Definition:Non-executive director (NED) | non-executive directors]] free from conflicts of interest, ensuring that appointments serve the company&amp;#039;s long-term interests rather than incumbent management preferences.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Fit and proper requirements]]&lt;br /&gt;
* [[Definition:Non-executive director (NED)]]&lt;br /&gt;
* [[Definition:Succession planning]]&lt;br /&gt;
* [[Definition:System of governance]]&lt;br /&gt;
* [[Definition:Senior Managers and Certification Regime (SM&amp;amp;CR)]]&lt;br /&gt;
* [[Definition:Key function holder]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>